Second, a study from a group in Hong Kong reported a 2-step approach using CK18 fragments and fibroblast growth factor 21 (FGF21) further improved the accuracy in diagnosing NASH. The gene discussed is FGF21; the disease is metabolic dysfunction-associated steatohepatitis.